Citigroup Inc Bio Rad Laboratories, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Citigroup Inc holds 22,501 shares of BIO stock, worth $7.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,501

Previous 26,515 15.14%

Holding current value

$7.68 Million

Previous $7.24 Million 3.96%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$263.97 - $344.64 $1.06 Million - $1.38 Million	-4,014 Reduced 15.14%	22,501 $7.53 Million
Q2 2024 Aug 12, 2024	BUY	$268.26 - $339.48 $3.93 Million - $4.97 Million	14,646 Added 123.4%	26,515 $7.24 Million
Q1 2024 May 10, 2024	BUY	$304.11 - $351.99 $72,986 - $84,477	240 Added 2.06%	11,869 $4.11 Million
Q4 2023 Feb 09, 2024	SELL	$269.37 - $365.04 $406,209 - $550,480	-1,508 Reduced 11.48%	11,629 $3.75 Million
Q3 2023 Nov 09, 2023	SELL	$350.25 - $422.63 $630,099 - $760,311	-1,799 Reduced 12.04%	13,137 $4.71 Million
Q2 2023 Aug 10, 2023	SELL	$359.49 - $486.4 $1.44 Million - $1.95 Million	-4,009 Reduced 21.16%	14,936 $5.66 Million
Q1 2023 May 11, 2023	BUY	$418.69 - $503.0 $1.29 Million - $1.55 Million	3,091 Added 19.5%	18,945 $9.08 Million
Q4 2022 Feb 09, 2023	SELL	$351.71 - $456.01 $804,360 - $1.04 Million	-2,287 Reduced 12.61%	15,854 $6.67 Million
Q3 2022 Nov 10, 2022	BUY	$412.59 - $563.26 $1.59 Million - $2.17 Million	3,851 Added 26.95%	18,141 $7.57 Million
Q2 2022 Aug 10, 2022	SELL	$463.67 - $597.16 $1.42 Million - $1.83 Million	-3,070 Reduced 17.68%	14,290 $7.07 Million
Q1 2022 May 12, 2022	BUY	$524.57 - $735.42 $660,433 - $925,893	1,259 Added 7.82%	17,360 $9.78 Million
Q4 2021 Feb 10, 2022	SELL	$708.84 - $794.68 $1.27 Million - $1.43 Million	-1,796 Reduced 10.04%	16,101 $12.2 Million
Q3 2021 Nov 10, 2021	BUY	$657.71 - $825.77 $11.8 Million - $14.8 Million	17,897 New	17,897 $13.4 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account